Protagonist Therapeutics' partners ought to secure two approvals for blockbuster drugs within the next year. Click here to ...

Emergent stock is down >40% since my last update. I had given the EBS stock a "Buy" rating but noted that 2025 may be a ...

The resale market for buyout funds has never been busier. From Blackstone to Ares, leading secondary investors shared their ...

In the high-stakes world of startup funding, first impressions are everything. Investors don’t have time to sift through a ...

College presentations are more than just visual aids. They are tools for expression, analysis, and creativity. Many students ...

Boelter first reached out to Kalech's firm for a book he had written, "Revoformation," which Kalech took to be a mashup between "revolution" and "reformation." It's also the name of the ministry ...

Abyss brings some great ideas to the competitive gacha market with its beta, but needs to fix a few fundamental issues.

Despite the spending review's boost for social homes, the government's headline housing pledge looks a long a shot as ever – ...

Indonesia’s state-owned power utility has backed away from promises to rapidly expand its use of renewable energy, opting to ...

I’m searching for the room where you throw tomatoes at a gimp. It’s an unholy hour at Dark Mofo’s Night Mass: God Complex, an ...

Real-time reactions during the CRM Playaz watch party for the Salesforce Connections 25 keynotes, featuring commentary from Alan Berkson, Liz Miller, Jon Reed, Bonnie Tinder, Rebecca Wettemann, and ...